Firebrick Pharma Ltd | ABN 64 157 765 896 | L14, 333 Collins St. Melbourne, VIC, 3000, Australia P : 1300 301 874 | W: firebrickpharma.com 11 August 2026 ASX Release Notice under Section 708A of the Corporations Act This notice is given by Firebrick Pharma Limited (...
Cleansing Notice
Filed with ASX ·
6ix hasn’t read this filing yet.
Firebrick Pharma Limited on 6ix
Earlier from Firebrick Pharma
- Application for quotation of securities - FRE
- Proposed issue of securities - FRE
- Investor Update
- March 2026 Quarterly Activity Report & Appendix 4C
- Firebrick Secures $1.5 million via Placement
Later from Firebrick Pharma
- Corporate Governance Statement
- Appendix 4G
- Appendix 4E and Annual Report 30 June 2026
- Notice of AGM and Closing Date for Director Nominations
- Firebrick receives $293,000 R&D Tax Incentive
Follow Firebrick Pharma into a list and get an email when it puts out news.
Follow Firebrick Pharma